Ozgen AG - Search Results

1

Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.

Eroglu Z, Cetinkalp S, Erdogan M, Kosova B, Karadeniz M, Kutukculer A, Gunduz C, Tetik A, Topcuoglu N, Ozgen AG, Tuzun M. Eroglu Z, et al. Among authors: ozgen ag. J Diabetes Complications. 2008 May-Jun;22(3):186-90. doi: 10.1016/j.jdiacomp.2006.12.004. Epub 2008 Apr 16. J Diabetes Complications. 2008. PMID: 18413162

2

Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter.

Ozgen AG, Hamulu F, Bayraktar F, Yilmaz C, Tüzün M, Yetkin E, Tunçyürek M, Kabalak T. Ozgen AG, et al. Thyroid. 1999 Jun;9(6):579-82. doi: 10.1089/thy.1999.9.579. Thyroid. 1999. PMID: 10411120 Clinical Trial.

3

A case of anti-islet-antibody-positive patient treated with insulin plus calcitriol.

Cetinkalp S, Hamulu F, Ozgen AG, Kavalali I, Kabalak T, Yilmaz C, Tüzün M. Cetinkalp S, et al. Among authors: ozgen ag. Endocr J. 1999 Dec;46(6):837-8. doi: 10.1507/endocrj.46.837. Endocr J. 1999. PMID: 10724361 Free article. No abstract available.

4

Long-term treatment with acarbose for the treatment of reactive hypoglycemia.

Ozgen AG, Hamulu F, Bayraktar F, Cetínkalp S, Yilmaz C, Túzún M, Kabalak T. Ozgen AG, et al. Eat Weight Disord. 1998 Sep;3(3):136-40. doi: 10.1007/BF03340001. Eat Weight Disord. 1998. PMID: 10728163

5

Acarbose treatment in obesity: a controlled study.

Bayraktar F, Hamulu F, Ozgen AG, Yilmaz C, Tüzün M, Kabalak T. Bayraktar F, et al. Among authors: ozgen ag. Eat Weight Disord. 1998 Mar;3(1):46-9. doi: 10.1007/BF03339987. Eat Weight Disord. 1998. PMID: 11234255 Clinical Trial.

6

Triiodothyronine antibodies in patients with goiter.

Ozgen AG, Kabalak T, Hamulu F, Bayraktar F, Yilmaz C, Yetkin E, Tüzün M. Ozgen AG, et al. Endocr Pract. 1999 Mar-Apr;5(2):72-5. doi: 10.4158/EP.5.2.72. Endocr Pract. 1999. PMID: 15251692

7

Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment.

Ozbek M, Erdogan M, Karadeniz M, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C, Tuzun M. Ozbek M, et al. Among authors: ozgen ag. Acta Diabetol. 2006 Dec;43(4):148-51. doi: 10.1007/s00592-006-0231-5. Acta Diabetol. 2006. PMID: 17211567 Clinical Trial.

8

Power Doppler US patterns of vascularity and spectral Doppler US parameters in predicting malignancy in thyroid nodules.

Tamsel S, Demirpolat G, Erdogan M, Nart D, Karadeniz M, Uluer H, Ozgen AG. Tamsel S, et al. Among authors: ozgen ag. Clin Radiol. 2007 Mar;62(3):245-51. doi: 10.1016/j.crad.2006.10.003. Clin Radiol. 2007. PMID: 17293218

9

The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.

Eroglu Z, Erdogan M, Tetik A, Karadeniz M, Cetinalp S, Kosova B, Gunduz C, Ozgen AG, Yilmaz C. Eroglu Z, et al. Among authors: ozgen ag. Diabetes Metab Res Rev. 2007 Nov;23(8):621-4. doi: 10.1002/dmrr.735. Diabetes Metab Res Rev. 2007. PMID: 17354258

10

Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.

Erdogan M, Karadeniz M, Berdeli A, Tamsel S, Ertan Y, Uluer H, Yilmaz C, Tuzun M, Kabalak T, Ozgen AG. Erdogan M, et al. Among authors: ozgen ag. J Endocrinol Invest. 2007 May;30(5):411-6. doi: 10.1007/BF03346319. J Endocrinol Invest. 2007. PMID: 17598974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters